Merck will stop testing an experimental combination treatment for skin cancer patients in a late-stage study, the drugmaker said May 13.

With fewer people applying for pharmacy degree programs and residencies, it's vital for health system leaders to foster the next generation of chief pharmacy officers, executives told Becker's.

A phase 3 trial failed to find progression-free survival among lung cancer patients, Bristol Myers Squibb said May 10. 

As drug shortages continue to affect day-to-day pharmacy operations and patient care, pharmacy leaders are turning to several strategies to help manage supply and mitigate impacts.

In a small trial of 14 patients, a CRISPR gene editing therapy improved vision among 11 participants, according to research led by a Mass General Brigham clinician. 

An FDA panel of independent advisers is set to consider the first potential new post-traumatic stress disorder treatment in 25 years — MDMA — NBC News reported May 7.

A boy has died in Pfizer's phase 2 study of its gene therapy candidate for Duchenne muscular dystrophy, a rare genetic disorder that primarily affects boys, according to a patient advocacy group. 

Patients of health systems that partner with RxLink will now receive pricing information on prescription medications offered through Mark Cuban's Cost Plus Drugs Co. 

Pharmacists are not often consulted in decision-making conversations about atrial fibrillation patients, the American Heart Association said, so the organization is working to engage pharmacists in AFib care. 

Duarte, Calif.-based City of Hope is collaborating with medical technology company Becton Dickinson to launch a new pharmacist residency program. 

On May 6, Pfizer appointed a former Citigroup executive as its chief strategy and innovation officer, executive vice president.

Following an HHS proposal, a Senate committee penned a bill to incentivize hospitals and other healthcare supply chain stakeholders for their drug shortage mitigation strategies, including stockpiles. 

In anticipation of a national shortage of hospital pharmacists, job postings increased by more than 12% in the first three months of 2024 compared to the first quarter of 2023. 

Select Walgreens pharmacies will host Boehringer Ingelheim's clinical trials, with a focus on recruiting people who are obese, overweight or have Type 2 diabetes, Walgreens said May 2. 

Emergent BioSolutions is consolidating operations, closing two manufacturing plants and laying off about 300 employees, the Maryland-based drugmaker said May 1. 

Louisville, Ky.-based ScionHealth will begin purchasing certain bulk drugs from Mark Cuban's Cost Plus Drug Co., the 94-hospital system said May 1. This marks Cost Plus Drugs' second health system partnership. 

The Federal Trade Commission sent letters to 10 drugmakers April 30 warning them that hundreds of patent listings for 20 drugs are invalid. The agency said "junk" listings keep drug prices high by stalling generic competition. 

Amazon's first-quarter earnings increased 225% in 2024 compared to last year, and the company listed its pharmacy services as one of its recent wins. 

Franklin, Tenn.-based Community Health Systems was the first health system to partner with and buy medicines manufactured by Mark Cuban Cost Plus Drug Co., and expects the partnership to result in significant advantages for its hospitals.

 The FDA has granted full approval for Pfizer's Tivdak (tisotumab vedotin-tftv) to treat cervical cancer in patients whose disease has progressed on or after chemotherapy.